VYNE Therapeutics Cash Flow Statement (2016-2025) | VYNE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Operating Activities
Net Income (Quarter)
-24.71M-23.18M-9.67M-9.24M-7.01M-3.20M13.36M-0.24M-0.20M-2.18M-0.01M-0.02M-0.51M-0.04M-0.01M-0.01M-0.01M-0.01M-0.01M
Depreciation and Depletion (Quarter)
0.01M0.01M
Share-based Compensation (Quarter)
2.62M2.95M2.44M1.90M2.40M1.33M0.89M1.16M1.17M1.07M0.86M0.88M0.86M0.71M0.98M0.89M0.73M0.70M0.76M0.53M
Gains from Investment Securities (Quarter)
-0.39M-0.07M0.07M0.08M-1.43M1.57M0.15M0.07M
Asset Writedowns and Impairment (Quarter)
1.60M1.60M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-23.64M-25.38M-12.55M-16.26M-17.54M-10.02M-9.04M-8.22M-7.12M-4.81M-5.48M-9.57M-5.15M-5.14M-7.98M-8.48M-8.54M-8.97M-11.50M-10.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.26M-0.78M-0.62M-0.51M-0.54M-0.32M-0.21M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.07M0.09M0.03M0.03M0.03M0.03M0.04M0.01M0.17M-0.15M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
-5.06M0.80M-1.00M-7.98M-0.23M0.17M-0.07M0.13M0.02M
Change in Inventory (Quarter)
0.85M0.75M0.69M0.19M-0.21M-0.78M-0.10M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
-0.89M-1.17M0.20M3.05M-3.09M-2.84M-9.60M-1.71M0.10M2.52M-0.51M-1.12M0.08M0.99M-0.61M3.52M0.90M2.20M-2.49M-6.41M
Other Working Capital Changes (Quarter)
1.58M-11.38M-0.01M-1.21M-0.23M-0.47M-1.04M-9.47M-0.53M0.53M0.21M-0.03M4.16M-4.21M0.99M0.77M-1.07M
Investing Activities
Capital Expenditures (Quarter)
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
15.75M-0.09M0.00M5.00M
Change in Acquisitions & Divestments (Quarter)
2.00M1.03M11.60M25.90M23.60M22.90M33.60M14.25M
Cash from Investing Activities (Quarter)
2.00M1.03M15.75M-0.09M0.00M5.00M-62.35M-3.57M19.02M-4.82M12.74M19.83M4.67M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
0.08M7.98M73.50M-0.13M-33.56M-0.04M1.53M-0.06M-0.03M0.21M-0.22M-0.01M-0.05M82.66M-0.01M-0.00M-0.00M-0.13M-0.09M-0.03M
Additional items
Exchange Rate Effect (Quarter)
0.00M-0.00M
Change in Cash (Quarter)
-23.55M-15.39M60.95M-15.36M-51.10M-10.06M8.24M-8.29M-7.24M-4.60M-0.69M-9.58M-5.20M15.17M-11.55M10.54M-13.34M3.61M8.28M-6.16M
Free Cash Flow (Quarter)
-23.64M-25.38M-12.55M-16.26M-17.54M-10.02M-9.04M-8.22M-7.12M-4.81M-5.48M-9.57M-5.15M-5.14M-7.98M-8.48M-8.54M-8.97M-11.50M-10.76M
Net Cash Flow (Quarter)
-23.55M-15.39M60.95M-15.36M-51.10M-10.06M8.24M-8.29M-7.24M-4.60M-0.69M-9.58M-5.20M15.17M-11.55M10.54M-13.36M3.63M8.24M-6.12M